United States Lupron Market Report 2016

November 2016 | 95 pages | ID: UB0E571A195EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Lupron

Revenue, means the sales value of Lupron

This report studies sales (consumption) of Lupron in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer, Inc. (US)
• AEterna Zentaris, Inc. (Canada)
• AstraZeneca Plc. (UK)
• Bayer HealthCare Pharmaceuticals, Inc. (USA)
• Eli Lilly and Company (USA)
• Meditrina Pharmaceuticals, Inc. (US)
• Neurocrine Biosciences, Inc. (US)
• Abbott Laboratories (USA)
• Repros Therapeutics, Inc. (US)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Lupron in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Lupron Market Report 2016

1 LUPRON OVERVIEW

1.1 Product Overview and Scope of Lupron
1.2 Classification of Lupron
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Lupron
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Lupron (2011-2021)
  1.4.1 United States Lupron Sales and Growth Rate (2011-2021)
  1.4.2 United States Lupron Revenue and Growth Rate (2011-2021)

2 UNITED STATES LUPRON COMPETITION BY MANUFACTURERS

2.1 United States Lupron Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Lupron Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Lupron Average Price by Manufactures (2015 and 2016)
2.4 Lupron Market Competitive Situation and Trends
  2.4.1 Lupron Market Concentration Rate
  2.4.2 Lupron Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES LUPRON SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Lupron Sales and Market Share by Type (2011-2016)
3.2 United States Lupron Revenue and Market Share by Type (2011-2016)
3.3 United States Lupron Price by Type (2011-2016)
3.4 United States Lupron Sales Growth Rate by Type (2011-2016)

4 UNITED STATES LUPRON SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Lupron Sales and Market Share by Application (2011-2016)
4.2 United States Lupron Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES LUPRON MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer, Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Lupron Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer, Inc. (US) Lupron Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 AEterna Zentaris, Inc. (Canada)
  5.2.2 Lupron Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 AEterna Zentaris, Inc. (Canada) Lupron Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 AstraZeneca Plc. (UK)
  5.3.2 Lupron Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 AstraZeneca Plc. (UK) Lupron Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Bayer HealthCare Pharmaceuticals, Inc. (USA)
  5.4.2 Lupron Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Bayer HealthCare Pharmaceuticals, Inc. (USA) Lupron Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Eli Lilly and Company (USA)
  5.5.2 Lupron Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Eli Lilly and Company (USA) Lupron Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Meditrina Pharmaceuticals, Inc. (US)
  5.6.2 Lupron Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Meditrina Pharmaceuticals, Inc. (US) Lupron Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Neurocrine Biosciences, Inc. (US)
  5.7.2 Lupron Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Neurocrine Biosciences, Inc. (US) Lupron Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Abbott Laboratories (USA)
  5.8.2 Lupron Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Abbott Laboratories (USA) Lupron Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Repros Therapeutics, Inc. (US)
  5.9.2 Lupron Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Repros Therapeutics, Inc. (US) Lupron Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview

6 LUPRON MANUFACTURING COST ANALYSIS

6.1 Lupron Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Lupron

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Lupron Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Lupron Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES LUPRON MARKET FORECAST (2016-2021)

10.1 United States Lupron Sales, Revenue Forecast (2016-2021)
10.2 United States Lupron Sales Forecast by Type (2016-2021)
10.3 United States Lupron Sales Forecast by Application (2016-2021)
10.4 Lupron Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Lupron
Table Classification of Lupron
Figure United States Sales Market Share of Lupron by Type in 2015
Table Application of Lupron
Figure United States Sales Market Share of Lupron by Application in 2015
Figure United States Lupron Sales and Growth Rate (2011-2021)
Figure United States Lupron Revenue and Growth Rate (2011-2021)
Table United States Lupron Sales of Key Manufacturers (2015 and 2016)
Table United States Lupron Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Lupron Sales Share by Manufacturers
Figure 2016 Lupron Sales Share by Manufacturers
Table United States Lupron Revenue by Manufacturers (2015 and 2016)
Table United States Lupron Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Lupron Revenue Share by Manufacturers
Table 2016 United States Lupron Revenue Share by Manufacturers
Table United States Market Lupron Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Lupron Average Price of Key Manufacturers in 2015
Figure Lupron Market Share of Top 3 Manufacturers
Figure Lupron Market Share of Top 5 Manufacturers
Table United States Lupron Sales by Type (2011-2016)
Table United States Lupron Sales Share by Type (2011-2016)
Figure United States Lupron Sales Market Share by Type in 2015
Table United States Lupron Revenue and Market Share by Type (2011-2016)
Table United States Lupron Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Lupron by Type (2011-2016)
Table United States Lupron Price by Type (2011-2016)
Figure United States Lupron Sales Growth Rate by Type (2011-2016)
Table United States Lupron Sales by Application (2011-2016)
Table United States Lupron Sales Market Share by Application (2011-2016)
Figure United States Lupron Sales Market Share by Application in 2015
Table United States Lupron Sales Growth Rate by Application (2011-2016)
Figure United States Lupron Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Lupron Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Lupron Sales Market Share (2011-2016)
Table AEterna Zentaris, Inc. (Canada) Basic Information List
Table AEterna Zentaris, Inc. (Canada) Lupron Sales, Revenue, Price and Gross Margin (2011-2016)
Table AEterna Zentaris, Inc. (Canada) Lupron Sales Market Share (2011-2016)
Table AstraZeneca Plc. (UK) Basic Information List
Table AstraZeneca Plc. (UK) Lupron Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca Plc. (UK) Lupron Sales Market Share (2011-2016)
Table Bayer HealthCare Pharmaceuticals, Inc. (USA) Basic Information List
Table Bayer HealthCare Pharmaceuticals, Inc. (USA) Lupron Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer HealthCare Pharmaceuticals, Inc. (USA) Lupron Sales Market Share (2011-2016)
Table Eli Lilly and Company (USA) Basic Information List
Table Eli Lilly and Company (USA) Lupron Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly and Company (USA) Lupron Sales Market Share (2011-2016)
Table Meditrina Pharmaceuticals, Inc. (US) Basic Information List
Table Meditrina Pharmaceuticals, Inc. (US) Lupron Sales, Revenue, Price and Gross Margin (2011-2016)
Table Meditrina Pharmaceuticals, Inc. (US) Lupron Sales Market Share (2011-2016)
Table Neurocrine Biosciences, Inc. (US) Basic Information List
Table Neurocrine Biosciences, Inc. (US) Lupron Sales, Revenue, Price and Gross Margin (2011-2016)
Table Neurocrine Biosciences, Inc. (US) Lupron Sales Market Share (2011-2016)
Table Abbott Laboratories (USA) Basic Information List
Table Abbott Laboratories (USA) Lupron Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Laboratories (USA) Lupron Sales Market Share (2011-2016)
Table Repros Therapeutics, Inc. (US) Basic Information List
Table Repros Therapeutics, Inc. (US) Lupron Sales, Revenue, Price and Gross Margin (2011-2016)
Table Repros Therapeutics, Inc. (US) Lupron Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Lupron
Figure Manufacturing Process Analysis of Lupron
Figure Lupron Industrial Chain Analysis
Table Raw Materials Sources of Lupron Major Manufacturers in 2015
Table Major Buyers of Lupron
Table Distributors/Traders List
Figure United States Lupron Production and Growth Rate Forecast (2016-2021)
Figure United States Lupron Revenue and Growth Rate Forecast (2016-2021)
Table United States Lupron Production Forecast by Type (2016-2021)
Table United States Lupron Consumption Forecast by Application (2016-2021)